Screener / SEC EDGAR /CIK 0001439222 /10-K filed Feb 12, 2026, compared with Feb 13, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Agios Pharmaceuticals, Inc. AGIO

Compare with peers Embed
Planned sales, announced before they happen

4 trading plans running, 23 Form 144 notices for $4.7M

10-Q, 10-K and Form 144
Plans running now 4 James Burns, Cecilia Jones, Sarah Gheuens, M.D., Ph.D., Tsveta Milanova
Plans adopted 11 reported since May 4, 2023 Form 144 notices 23 $4.7M the sellers expected to sell

What AGIO's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Aug 3, 2024 to Dec 10, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
James Burns
Chief Legal Officer
Adopted 10b5-1 plan Sep 14, 2026 10-Q Nov 5, 2026
Cecilia Jones
Chief Financial Officer
Adopted 10b5-1 plan May 1, 2026 10-Q Jul 30, 2026
Sarah Gheuens, M.D., Ph.D.
Chief Medical Officer, Head of Research & Development
Adopted 10b5-1 plan May 1, 2026 10-Q Jul 30, 2026
Tsveta Milanova
Chief Commercial Officer
Adopted 10b5-1 plan May 1, 2026 10-Q Jul 30, 2026
Sarah Gheuens, M.D., Ph.D.
Chief Medical Officer, Head of Research & Development
Adopted 10b5-1 plan Feb 25, 2025 10-Q May 1, 2025
Cecilia Jones
Chief Financial Officer
Adopted 10b5-1 plan Dec 13, 2024 10-K Feb 13, 2025
Tsveta Milanova
Chief Commercial Officer
Adopted 10b5-1 plan Dec 13, 2024 10-K Feb 13, 2025
David Scadden
Director
Adopted 10b5-1 plan Sep 6, 2024 10-Q Oct 31, 2024
James Burns
Chief Legal Officer
Adopted 10b5-1 plan Aug 5, 2024 10-Q Oct 31, 2024
Rahul Ballal
Director
Adopted 10b5-1 plan Aug 3, 2024 10-Q Oct 31, 2024
Sarah Gheuens
chief medical officer and head of research & development
Adopted 10b5-1 plan – 10-Q Nov 2, 2023
Show the other 3 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Oct 26, 2026 SARAH GHEUENS
Officer
7,866 $296K
Oct 22, 2026 SARAH GHEUENS
Officer
500 $19K
Oct 21, 2026 SARAH GHEUENS
Officer
1,489 $56K
Aug 4, 2026 SARAH GHEUENS
Officer
30,000 $914K
Jul 1, 2026 Gheuens Sarah
Officer
4,007 $151K
Apr 2, 2026 Goff Brian
Officer, Director
19,068 $652K
Apr 2, 2026 Jones Cecilia
Officer
3,141 $107K
Apr 2, 2026 Viswanadhan Krishnan
Officer
2,959 $101K
Apr 2, 2026 Milanova Tsveta
Officer
3,262 $112K
Apr 2, 2026 Gheuens Sarah
Officer
2,940 $101K
Apr 2, 2026 Burns James William
Officer
3,280 $112K
Mar 5, 2026 Viswanadhan Krishnan
Officer
2,959 $86K
Mar 2, 2026 Goff Brian
Officer, Director
18,055 $546K
Mar 2, 2026 Burns James William
Officer
5,218 $158K
Mar 2, 2026 Gheuens Sarah
Officer
4,055 $123K
Mar 2, 2026 Jones Cecilia
Officer
5,035 $152K
Mar 2, 2026 Milanova Tsveta
Officer
2,868 $87K
Jan 5, 2026 Milanova Tsveta
Officer
2,872 $78K
Dec 30, 2025 Goff Brian
Officer, Director
18,703 $508K
Dec 30, 2025 Gheuens Sarah
Officer
2,932 $80K
Dec 30, 2025 Jones Cecilia
Officer
2,932 $80K
Dec 30, 2025 Milanova Tsveta
Officer
2,932 $80K
Dec 30, 2025 Burns James William
Officer
2,932 $80K
Show the other 15 notices

From the Form 144 XML filed with the SEC, since Dec 30, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/AGIO/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.